Skip to main content
. Author manuscript; available in PMC: 2019 May 15.
Published in final edited form as: Neuropharmacology. 2017 Sep 5;134(Pt A):13–21. doi: 10.1016/j.neuropharm.2017.09.004

Figure 1.

Figure 1

Top panel – Locomotor effects of 10 mg/kg MDPV following saline (circles), 10 mg/kg bupropion (triangles), 3 mg/kg desipramine (squares), or 3 mg/kg fluoxetine (diamonds) pretreatment at an ambient temperature of 20°C (left panel, white symbols) or 28°C (right panel, black symbols) in NIH Swiss mice (n=5–6). Abscissa: ‘BL’ denotes 30 min baseline data collected before injection, while ‘PT’ denotes data during the 30 min pretreatment. Numbers refer to time, in minutes, following MDPV administration. Ordinate: mean activity counts calculated in 30 min bins. Lower panel – Locomotor effects of MDPV following pretreatment with saline or a monoamine reuptake inhibitor at an ambient temperature of 20°C (white bars) or 28°C (black bars). Abscissa: ‘SAL,’ ‘Bupropion,’ ‘Desipramine,’ and ‘Fluoxetine’ represent data following pretreatments as described above. Ordinate: mean total activity elicited by MDPV, recorded over 6 hr. Number sign indicates significant difference between ambient temperature conditions, p<0.05.